Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UA007 in acute gout flare with chronic kidney disease (Phase IIb, randomized, double-blind, active-controlled)
CTR20260955Phase 2Active
- Sponsor
- Jiaochen Biopharmaceutical
- Start
- Mar 2026
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of UA007 in gout, sponsored by Jiaochen Biopharmaceutical. Started Mar 2026; status: active.
02
Drugs
UA007
03
Conditions
gout
Beyond the preview
Go deeper on CTR20260955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260955.